| P50 | author | Tarek Mazzawi | Q43161716 |
| | Magdy El-Salhy | Q87422049 |
| P2860 | cites work | Relevance of protein fermentation to gut health | Q37961650 |
| | Intestinal sensing of nutrients | Q37976365 |
| | Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells | Q37983846 |
| | Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome | Q24244169 |
| | Prevalence of irritable bowel syndrome: a community survey | Q24535897 |
| | The role of genetics in IBS. | Q24600235 |
| | Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing | Q24604695 |
| | Enteroendocrine cells: neglected players in gastrointestinal disorders? | Q24629026 |
| | Functional bowel disorders and functional abdominal pain | Q24675171 |
| | Diet in irritable bowel syndrome | Q26824367 |
| | Unraveling the ties between irritable bowel syndrome and intestinal microbiota | Q27004645 |
| | The chromogranin-secretogranin family | Q28185052 |
| | Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management | Q28265447 |
| | Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing | Q28273361 |
| | Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats | Q28566362 |
| | Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4 | Q28592260 |
| | Ageing and endocrine cells of human duodenum | Q28609223 |
| | Functional bowel disorders | Q29620328 |
| | Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides | Q30487228 |
| | Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials | Q33255725 |
| | The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects | Q33290848 |
| | Evaluation of the Birmingham IBS symptom questionnaire | Q33354600 |
| | Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion | Q33435497 |
| | Gut endocrine cell development | Q37660584 |
| | Molecular mechanisms underlying nutrient-stimulated incretin secretion | Q37667168 |
| | Taste, visceral information and exocrine reflexes with glutamate through umami receptors | Q37707754 |
| | Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker | Q37779812 |
| | A review of the irritable bowel syndrome investigation on epidemiology, pathogenesis and pathophysiology in China | Q37858646 |
| | Food intolerance in functional bowel disorders | Q37858653 |
| | Classification and functions of enteroendocrine cells of the lower gastrointestinal tract | Q37868714 |
| | Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome | Q33447288 |
| | Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. | Q33450566 |
| | Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway | Q33456089 |
| | The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. | Q33458071 |
| | Nutrient Tasting and Signaling Mechanisms in the Gut III. Endocrine cell recognition of luminal nutrients | Q33796494 |
| | Dietary intakes in people with irritable bowel syndrome. | Q33811317 |
| | Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). | Q33890272 |
| | Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome | Q33898224 |
| | Dietary modulation of the human colonic microbiota: updating the concept of prebiotics | Q34015209 |
| | Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach | Q34021193 |
| | A diet low in FODMAPs reduces symptoms of irritable bowel syndrome | Q34038352 |
| | Review article: the economic impact of the irritable bowel syndrome | Q34041951 |
| | Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon | Q34094836 |
| | Treatment of irritable bowel syndrome: a review of randomised controlled trials | Q34130605 |
| | Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. | Q34155802 |
| | Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. | Q34165544 |
| | Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types | Q34210313 |
| | Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. | Q34284553 |
| | Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population | Q34296250 |
| | Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. | Q34301065 |
| | Defining and diagnosing irritable bowel syndrome. | Q34320375 |
| | Irritable bowel syndrome: toward a cost-effective management approach. | Q34320391 |
| | A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function | Q34324881 |
| | Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome | Q34341766 |
| | U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact | Q34353536 |
| | Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion. | Q34387519 |
| | Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome | Q34426842 |
| | Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences | Q34481544 |
| | Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. | Q34524930 |
| | The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man. | Q34525466 |
| | Small bowel resistances and the gastroduodenal brake | Q34528332 |
| | Food intolerance and the irritable bowel syndrome | Q34532110 |
| | Age-related changes in neuroendocrine system of the gut. A possible role in the pathogenesis of gastrointestinal disorders in the elderly. Minireview based on a doctoral thesis | Q34558330 |
| | Prevalence of irritable bowel syndrome: a community based study from northern India | Q34588809 |
| | The role of diet in the pathogenesis and management of irritable bowel syndrome (Review). | Q37988313 |
| | Food choice as a key management strategy for functional gastrointestinal symptoms | Q38001288 |
| | Irritable bowel syndrome: the role of gut neuroendocrine peptides | Q38015086 |
| | Dietary lipids and functional gastrointestinal disorders | Q38097270 |
| | Pathogenesis of irritable bowel syndrome--review regarding associated infection and immune activation. | Q38109820 |
| | Functional bowel symptoms and diet | Q38153425 |
| | On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens | Q38179528 |
| | Is irritable bowel syndrome an organic disorder? | Q38191561 |
| | Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment | Q38192048 |
| | Effect of dietary fiber on properties and acceptance of meat products: a review | Q38219128 |
| | American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation | Q38236812 |
| | Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis | Q38372760 |
| | Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome | Q39166000 |
| | Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence | Q39320245 |
| | Irritable Bowel Syndrome and Health-Related Quality of Life: A Population-Based Study in Calgary, Alberta | Q39647523 |
| | Cellular kinetics of gastrointestinal mucosa, with special reference to gut endocrine cells. | Q40155192 |
| | Gastrointestinal neurotransmitters. | Q40621768 |
| | Origin and differentiation of gut endocrine cells | Q40838898 |
| | The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors | Q41027346 |
| | Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance | Q41132023 |
| | The fecal microbial population in the irritable bowel syndrome. | Q41625029 |
| | Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? | Q41849440 |
| | Irritable bowel syndrome in office-based practice in the United States | Q41878297 |
| | Dietary modification as a treatment for irritable bowel syndrome. | Q42085929 |
| | Low density of ghrelin cells in the oxyntic mucosa correlated to slow gastric emptying in patients with type 1 diabetes | Q42743469 |
| | Gastrointestinal adaptation to diets of differing fat composition in human volunteers | Q43048461 |
| | Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome | Q43124191 |
| | Effects of nutrient liquids on human gastroduodenal motor activity | Q43256120 |
| | Functional bowel disorders in apparently healthy people | Q43325684 |
| | A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome | Q43341145 |
| | Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors | Q43342235 |
| | Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. | Q43361470 |
| | Bowel disorders impair functional status and quality of life in the elderly: a population-based study | Q43414048 |
| | Functional disorders of the colon | Q43495978 |
| | Food-related gastrointestinal symptoms in the irritable bowel syndrome | Q43539583 |
| | Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index | Q43696884 |
| | Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire | Q44056837 |
| | Abnormal rectal endocrine cells in patients with irritable bowel syndrome | Q44601148 |
| | Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome | Q44666617 |
| | Wnts as essential growth factors for the adult small intestine and colon. | Q45978930 |
| | Jejunal brake: inhibition of intestinal transit by fat in the proximal small intestine | Q46241970 |
| | Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome | Q46256357 |
| | Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome | Q46496767 |
| | Racial differences in the impact of irritable bowel syndrome on health-related quality of life | Q46535231 |
| | Guidelines on the irritable bowel syndrome: mechanisms and practical management. | Q34626602 |
| | Fructan and free fructose content of common Australian vegetables and fruit | Q34649339 |
| | Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study | Q34745942 |
| | Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome | Q34786704 |
| | Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). | Q34915421 |
| | The possible role of the gut neuroendocrine system in diabetes gastroenteropathy | Q34950672 |
| | A systematic review of alternative therapies in the irritable bowel syndrome | Q35063731 |
| | Prebiotics and calcium bioavailability | Q35105593 |
| | Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome | Q35291806 |
| | Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population | Q35353623 |
| | Irritable bowel syndrome in general practice: prevalence, characteristics, and referral | Q35358389 |
| | Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance | Q35416179 |
| | Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt | Q35548221 |
| | Irritable bowel syndrome in the general population | Q35819583 |
| | Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome | Q35837381 |
| | Intestinal microecology and quality of life in irritable bowel syndrome patients | Q36065979 |
| | Prebiotics and resistance to gastrointestinal infections | Q36118684 |
| | Irritable bowel syndrome: diagnosis and pathogenesis | Q36310403 |
| | Chromogranin A cell density in the rectum of patients with irritable bowel syndrome | Q36383202 |
| | Neuroendocrine design of the gut | Q36483375 |
| | Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome | Q36552750 |
| | Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences | Q36674023 |
| | Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance | Q36791242 |
| | Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders | Q36903022 |
| | Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus | Q37175498 |
| | Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome | Q37204274 |
| | The intestinal stem cell | Q37217105 |
| | Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters | Q37458736 |
| | The role of diet in symptoms of irritable bowel syndrome in adults: a narrative review | Q37532807 |
| | The burden of IBS: looking at metrics | Q37554868 |
| | Endocrine cells in the ileum of patients with irritable bowel syndrome | Q37617989 |
| | Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). | Q37626581 |
| | Irritable bowel syndrome: emerging paradigm in pathophysiology | Q37629670 |
| | The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity | Q37636996 |
| | Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome | Q48463692 |
| | High-fat diet effects on gut motility, hormone, and appetite responses to duodenal lipid in healthy men. | Q48616153 |
| | Tracking down the stem cells of the intestine: strategies to identify adult stem cells | Q48894577 |
| | Modulation of gut mucosal biofilms | Q50091132 |
| | The burden of selected digestive diseases in the United States | Q50113541 |
| | The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects | Q50171831 |
| | What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). | Q51753911 |
| | Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. | Q51803884 |
| | Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? | Q51971888 |
| | Molecular mechanisms of enteroendocrine differentiation. | Q52179994 |
| | What is the developmental fate of the neural crest cells which migrate into the pancreas in the avian embryo? | Q52306224 |
| | Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. | Q53348988 |
| | Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form. | Q53501527 |
| | Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. | Q53524367 |
| | Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population | Q57840344 |
| | A randomly selected population sample undergoing colonoscopy | Q63532490 |
| | Types of endocrine cells in the human colon and rectum | Q67390784 |
| | Effect of different caloric loads in human jejunum on meal-stimulated and nonstimulated biliopancreatic secretion | Q68281151 |
| | Survey of the AGA membership relating to patients with functional gastrointestinal disorders | Q68959342 |
| | The migration of neural crest cells to the wall of the digestive tract in avian embryo | Q69570279 |
| | Inhibitory effect of high caloric load of carbohydrates or lipids on human pancreatic secretions: a jejunal brake | Q69672613 |
| | Prognosis in the irritable bowel syndrome: a 5-year prospective study | Q69896917 |
| | The enteric nervous system | Q70995216 |
| | Medical costs in community subjects with irritable bowel syndrome | Q71584338 |
| | Impact of irritable bowel syndrome on quality of life | Q71835032 |
| | Organic and functional disorders in 2000 gastroenterology outpatients | Q72546989 |
| | Quality of life in persons with irritable bowel syndrome: development and validation of a new measure | Q74343827 |
| | Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients | Q78001477 |
| | Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients | Q79735190 |
| | Dissimilatory amino Acid metabolism in human colonic bacteria | Q80057162 |
| | Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome | Q84524629 |
| | Nutrient intake in patients with irritable bowel syndrome compared with the general population | Q84909219 |
| | Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome | Q86143124 |
| | Diets that differ in their FODMAP content alter the colonic luminal microenvironment | Q87389891 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell | Q7868 |
| | irritable bowel syndrome | Q838966 |
| | endocrine system | Q11078 |
| | carbohydrate | Q11358 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 943-952 | |
| P577 | publication date | 2017-08-11 | |
| | 2017-10-01 | |
| P1433 | published in | International Journal of Molecular Medicine | Q6051492 |
| P1476 | title | Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). | |
| P478 | volume | 40 | |